SPRO

Spero Therapeutics News

Company Name Stock Ticker Symbol Market Type
Spero Therapeutics Inc SPRO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.06 -3.28% 1.77 17:00:00
Open Price Low Price High Price Close Price Prev Close
1.83 1.73 1.83 1.77 1.83
more quote information »

Recent News

Date Time Source Heading
12/07/20228:55IHNWFeaturedWorldwide Crypto Based Exchange Traded Products AUM Dropped 17% in November
11/22/202208:05GLOBESpero Therapeutics to Present at the 5th Annual Evercore ISI..
11/15/202206:01EDGARSmall Company Offering and Sale of Securities Without..
11/14/202217:37EDGARInitial Statement of Beneficial Ownership (3)
11/14/202217:35EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
11/14/202216:37EDGARSecurities Registration: Employee Benefit Plan (s-8)
11/14/202216:08EDGARQuarterly Report (10-q)
11/14/202216:05GLOBESpero Therapeutics Announces Third Quarter 2022 Operating..
11/08/202208:05GLOBESpero Therapeutics Announces Closing of Exclusive License..
11/07/202208:05GLOBESpero Therapeutics to Provide Business Update and Report..
10/19/202208:05GLOBESpero Therapeutics to Present Data at IDWeek 2022
10/03/202208:05GLOBESpero Therapeutics to Host Virtual R&D Event on..
9/26/202215:32EDGARStatement of Changes in Beneficial Ownership (4)
9/26/202206:25TRMNH.C. Wainwright Reaffirms Their Buy Rating on Spero..
9/23/202208:35TRMNPositive Report for Spero Therapeutics (SPRO) from Evercore..
9/22/202210:20APSMicro Cap Up Over +100% In Premarket
9/22/202208:01EDGARCurrent Report Filing (8-k)
9/22/202206:57TRMNSpero Therapeutics (NASDAQ:SPRO) Soars on Major GSK Deal
9/22/202206:30DJNSpero Therapeutics Shares Take Flight Premarket on GSK Pact
9/22/202202:00GLOBEGSK and Spero Therapeutics Announce Exclusive License..
9/19/202217:45EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202217:45EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202217:44EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202217:44EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202217:41EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202217:40EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202217:40EDGARStatement of Changes in Beneficial Ownership (4)
9/15/202216:05GLOBESpero Therapeutics Announces Appointment of Kamal Hamed, MD,..
9/07/202208:05GLOBESpero Therapeutics to Present at Upcoming Investor..
9/07/202207:50TRMNAnalysts Are Bullish on Top Healthcare Stocks: Spero..
9/06/202211:45DJNSpero Therapeutics Shares Up 38% On FDA's Feedback of..
9/06/202208:16EDGARCurrent Report Filing (8-k)
9/06/202208:05GLOBESpero Therapeutics Provides Tebipenem HBr Program Update..
8/15/202206:35TRMNH.C. Wainwright Reaffirms Their Buy Rating on Spero..
8/10/202216:10EDGARCurrent Report Filing (8-k)
8/10/202216:05EDGARQuarterly Report (10-q)
8/10/202216:05GLOBESpero Therapeutics Announces Second Quarter 2022 Operating..
8/09/202208:05GLOBESpero Therapeutics to Provide Business Update and Report..
8/05/202216:09EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/22/202205:45PRNUSSPRO SHAREHOLDER ALERT: Jakubowitz Law Reminds Spero..
7/20/202205:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
7/15/202205:45PRNUSSPRO SHAREHOLDER ALERT: Jakubowitz Law Reminds Spero..
7/13/202205:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
7/08/202217:01EDGARStatement of Ownership (sc 13g)
7/08/202206:25TRMNH.C. Wainwright Reiterates Their Buy Rating on Spero..
7/08/202205:45PRNUSSPRO SHAREHOLDER ALERT: Jakubowitz Law Reminds Spero..
7/06/202205:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
7/01/202216:07EDGARCurrent Report Filing (8-k)
7/01/202205:45PRNUSSPRO SHAREHOLDER ALERT: Jakubowitz Law Reminds Spero..
6/29/202212:30PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
6/27/202216:12EDGARCurrent Report Filing (8-k)